Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025

Rhea-AI Summary

Kiniksa Pharmaceuticals (Nasdaq: KNSA) has scheduled its first quarter 2025 financial results conference call and webcast for Tuesday, April 29, 2025 at 8:30 a.m. Eastern Time. The company will discuss Q1 2025 financial performance and recent portfolio developments.

The event will be accessible through a live webcast in the Investors & Media section of www.kiniksa.com. Interested participants can register for telephone access, after which they will receive confirmation details including dial-in information and unique access credentials. A replay will be available on the company website within 48 hours after the event.

LONDON, April 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 29, 2025 at 8:30 a.m. Eastern Time to report its first quarter 2025 financial results and recent portfolio execution.

A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts!^®

Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com

FAQ

When will Kiniksa Pharmaceuticals (KNSA) release Q1 2025 earnings?

Kiniksa Pharmaceuticals will release Q1 2025 earnings on Tuesday, April 29, 2025 at 8:30 a.m. Eastern Time.

How can investors access KNSA's Q1 2025 earnings call?

Investors can access the call via webcast through Kiniksa's website (www.kiniksa.com) or register for telephone access.

Will there be a replay available for Kiniksa's Q1 2025 earnings call?

Yes, a replay will be available on Kiniksa's website within 48 hours after the event.

What topics will be covered in KNSA's Q1 2025 earnings call?

The call will cover Q1 2025 financial results and recent portfolio execution updates.